and in revised form February 29, 1988; accepted March 8, 1988 (7A1 182 was applied at a dilution of 1 :soo in PBS for 30 mm at room temperature. Before the immunobabebing procedure, sections were treated with 4% sodium metaperiodate to reveal or enhance antigen accessibility on the surface of the section (9, 10) . A step to block nonspecific labeling, using bovine serum albumin (BSA) for 10 mm, was also employed before incubation with the primary antibody. Double immunogold labeling was done first for chromogranin A, localized with 5-nm lgG-gold (Janssen Pharmaceutica; Beerse, Bebgium), and 
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?' *' Figure 3 . Double-immunogold labeling for chromogranin A (5-nm gold) and calcitonin (20-nm gold) shows that both antigens are distributed randomly in the matrix of secretory granules.
One granule is sectioned through its periphery (arrowhead).
Original magnification
x 141,000. Bar = 0.025 tim. 
